Synageva BioPharma Corp (GEVA.OQ)

GEVA.OQ on NASDAQ Stock Exchange Global Select Market

81.20USD
28 Nov 2014
Price Change (% chg)

$-0.96 (-1.17%)
Prev Close
$82.16
Open
$82.65
Day's High
$84.53
Day's Low
$80.69
Volume
52,880
Avg. Vol
98,187
52-wk High
$119.04
52-wk Low
$59.82

GEVA.OQ

Chart for GEVA.OQ

About

Synageva BioPharma Corp. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threa... (more)

Overall

Beta: 0.80
Market Cap (Mil.): $2,729.23
Shares Outstanding (Mil.): 33.22
Dividend: --
Yield (%): --

Financials

  GEVA.OQ Industry Sector
P/E (TTM): -- 212.78 38.55
EPS (TTM): -5.14 -- --
ROI: -33.70 -2.36 17.25
ROE: -33.94 -3.67 18.17
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics Prime
$10.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks